Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

14.3%

2 terminated out of 14 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

21%

3 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results60% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (6)
P 2 (1)
P 3 (3)

Trial Status

Unknown3
Completed3
Suspended2
Terminated2
Withdrawn2
Recruiting1

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
Showing all 14 trials

Research Network

Activity Timeline